Research

Next UK Cannabis Center seminar focuses on recreational, medical cannabis, health equity

LaTrice Montgomery, Ph.D., is a research associate professor and licensed clinical psychologist in the Department of Psychiatry and Behavioral Neuroscience in the College of Medicine at the University of Cincinnati. Photo provided by UK Cannabis Center.

LEXINGTON, Ky. (Aug. 10, 2023) — The University of Kentucky Cannabis Center is sponsoring a series of seminars featuring national and international experts on cannabis science. This series will give UK students, faculty and the general public the chance to hear cutting-edge cannabinoid science across a wide variety of specialties (medicine, pharmacology, public health, impaired driving science, agriculture, legal and social justice). 

The center, based in the UK College of Medicine’s Center on Drug and Alcohol Research (CDAR), conducts research on the health effects of cannabis, including its risks and benefits when used to treat certain medical conditions.

The next seminar will highlight the work of LaTrice Montgomery, Ph.D., a research associate professor and licensed clinical psychologist in the Department of Psychiatry and Behavioral Neuroscience in the College of Medicine at the University of Cincinnati. Montgomery will present “Research Discoveries in the Recreational and Medical Worlds of Cannabis.”

Montgomery’s work primarily focuses on the co-use of marijuana and tobacco, especially via blunts, technology-based interventions for substance use disorders and advancing health equity. She has presented her award-winning research at several regional and national conferences, and it has been published in top-tier journals, including Drug and Alcohol Dependence and the Journal of Consulting and Clinical Psychology.

“Dr. Montgomery’s work adds valuable data to this growing research landscape and helps us understand some of the real-world complexities surrounding cannabis use. We are grateful to give our colleagues at UK and members of the public interested the opportunity to hear from her,” said Center Director Shanna Babalonis, Ph.D. “This seminar series, and engaging with experts like Dr. Montgomery, helps us continue to the Center’s mission to accelerate cannabinoid science and conduct pertinent, top-tier research that directly addresses the health and well-being of the people of Kentucky.”

The seminar is co-sponsored by the UK Center for Health Equity Transformation and will be held via Zoom on Tuesday, Aug. 22 from 11 a.m. - noon EST. The seminar is open to all. Register online here.

To receive information on upcoming events, please contact the UK Cannabis Center at cannabiscenter@uky.edu.

About the UK Cannabis Center
The UK Cannabis Center conducts research on the health effects of cannabis, including its risks and benefits when used to treat certain medical conditions. It was established in 2022 by Kentucky House Bill 604 and appropriated $2 million through June 2024.

As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.